Sort   by:  
 Page size 
ProteomicsChange of Ranibizumab-induced Human Vitreous Protein Profile in Patients with Proliferative Diabetic Retinopathy Based on Proteomics Analysis
Background: Preoperative treatment of anti-vascular endothelial growth factor (VEGF) agents is extensively used in proliferative diabetic retinopathy (PDR), but the molecular mechanism is not fully understood. The objective of this research is to observe change of protein profile induced by Ranibizu...
ORGANISM(S): Homo sapiens (Human) 
2018-10-19 | PXD008901 | Pride
Proteomics  proliferative diabetic retinopathy  ranibizumab 
UnknownSerious Adverse Events with Bevacizumab or Ranibizumab for Age-related Macular Degeneration: Meta-analysis of Individual Patient Data.
Not available
S-EPMC5640431 | biostudies-literature
Genomics
Phage panning for ranibizumab
PRJNA487034 | ENA
GenomicsInjectable anti-inflammatory supramolecular nanofiber hydrogel to promote ranibizumab therapy in age-related macular degeneration treatment
Injectable anti-inflammatory supramolecular nanofiber hydrogel to promote ranibizumab therapy in age-related macular degeneration treatment
PRJNA695504 | ENA
ProteomicsProtein profile analysis of 12 human vitreous samples using labelfree method
To study the differences in protein profiles before and after intravitreal ranibizumab (IVR) treatment, 12 vitreous humor (VH) samples were collected from 6 proliferative diabetic retinopathy (PDR) patients before (pre group) and after IVR treatment (post group). LC–MS/MS and bioinformatics analysis...
ORGANISM(S): Homo sapiens (Human) 
2022-08-12 | PXD027592 | Pride
Proliferative diabetic retinopathy  proteomics  ranibizumab  label-free  lc–ms/ms  prm 
UnknownComparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial.
Not available
S-EPMC5840003 | biostudies-literature
TranscriptomicsInjectable anti-inflammatory supramolecular nanofiber hydrogel to promote ranibizumab therapy in age-related macular degeneration treatment
The exact pathogenesis of age-related macular degeneration (AMD) leading to visual impairment and severe vision loss is still unclear, and the currently available treatments are often unsatisfactory. Previous studies have demonstrated both oxidative stress-induced damage to the retinal pigment epith...
ORGANISM(S): Mus musculus 
2024-01-28 | GSE165702 | GEO
UnknownCurrent perspectives on ranibizumab.
Not available
S-EPMC4376306 | biostudies-literature
UnknownFive-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema.
Not available
S-EPMC4811755 | biostudies-literature
UnknownRanibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study.
Not available
S-EPMC7773197 | biostudies-literature
Sort   by:  
 Page size